VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MMC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MMCMarsh & McLennan Companies, Inc.
$174.06$85.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMMCQuarterly Financials

Marsh & McLennan Companies, Inc. (MMC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Marsh & McLennan Companies, Inc. (MMC) quarterly income statement — complete revenue, gross profit & net income history

MMC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20
Revenue6.35B6.97B7.06B6.07B5.7B6.22B6.47B5.55B5.38B5.88B5.92B5.02B4.77B5.38B5.55B5.14B4.58B5.02B5.08B4.42B
Revenue Growth %11.48%12.1%9.08%9.24%5.85%5.87%9.27%10.59%12.83%9.24%6.76%-2.24%4.08%7.22%9.17%16.33%15.5%19.77%9.29%3.56%
Medical Costs & Claims3.89B3.9B3.85B3.63B3.44B3.45B3.47B3.27B3.29B3.34B3.21B3.04B2.92B3.01B3.1B2.9B2.85B2.86B2.81B2.65B
Medical Cost Ratio %61.31%55.85%54.52%59.83%60.42%55.52%53.61%58.84%61.07%56.79%54.14%60.49%61.28%55.96%55.87%56.55%62.25%57.01%55.22%60.01%
Gross Profit2.46B3.08B3.21B2.44B2.25B2.77B3B2.29B2.1B2.54B2.72B1.98B1.85B2.37B2.45B2.23B1.73B2.16B2.28B1.77B
Gross Margin %38.69%44.15%45.48%40.17%39.58%44.48%46.39%41.16%38.93%43.21%45.86%39.51%38.72%44.04%44.13%43.45%37.75%42.99%44.78%39.99%
Gross Profit Growth %8.96%11.28%6.93%6.61%7.64%8.98%10.53%15.22%13.43%7.18%10.94%-11.11%6.76%9.83%7.6%26.39%17.45%22.56%8.59%-1.12%
Operating Expenses1.29B1.25B1.21B1.29B1.15B1.13B1.08B1.18B1.1B1.08B991M1.3B1.06B1B1B1.25B990M929M918M1.2B
OpEx / Revenue %20.26%17.92%17.08%21.34%20.13%18.08%16.65%21.3%20.42%18.41%16.73%25.97%22.14%18.68%18.09%24.26%21.6%18.52%18.06%27.06%
Depreciation & Amortization224M231M227M201M180M176M189M186M180M178M169M202M169M168M180M178M179M193M197M194M
Combined Ratio %81.58%73.77%71.6%81.18%80.55%73.61%70.26%80.14%81.49%75.2%70.86%86.46%83.42%74.64%73.96%80.81%83.85%75.52%73.28%87.07%
Operating Income1.17B1.83B2B1.14B1.11B1.64B1.93B1.1B996M1.46B1.73B680M791M1.36B1.45B986M740M1.23B1.36B571M
Operating Margin %18.42%26.23%28.4%18.82%19.45%26.39%29.74%19.86%18.51%24.8%29.14%13.54%16.58%25.36%26.04%19.19%16.15%24.48%26.72%12.93%
Operating Income Growth %5.6%11.39%4.16%3.54%11.24%12.7%11.53%62.21%25.92%6.82%19.45%-31.03%6.89%11.07%6.41%72.68%37.04%38.76%26.92%-3.55%
EBITDA1.39B2.06B2.23B1.34B1.29B1.82B2.11B1.29B1.18B1.64B1.9B882M960M1.53B1.63B1.16B919M1.42B1.55B765M
EBITDA Margin %21.95%29.54%31.61%22.14%22.61%29.22%32.66%23.21%21.85%27.83%31.99%17.56%20.13%28.48%29.28%22.66%20.05%28.32%30.59%17.32%
Interest Expense237M243M245M231M154M156M159M151M145M146M136M127M118M114M110M109M107M110M118M128M
Non-Operating Income-77M-60M-67M-98M-81M-79M-105M-96M-79M-73M-74M-60M-60M-62M-89M-84M-83M-91M-82M-97M
Pretax Income1.01B1.65B1.83B1.01B1.03B1.56B1.87B1.05B930M1.38B1.66B613M733M1.31B1.42B961M716M1.21B1.32B540M
Pretax Margin %15.9%23.6%25.87%16.63%18.17%25.16%28.9%18.87%17.28%23.55%28.09%12.21%15.37%24.39%25.66%18.71%15.62%24.1%26.01%12.23%
Income Tax253M415M415M208M283M425M447M283M192M337M412M142M181M334M338M154M174M382M324M161M
Effective Tax Rate %25.05%25.21%22.71%20.61%27.34%27.16%23.89%27%20.65%24.35%24.76%23.16%24.69%25.46%23.74%16.02%24.3%31.6%24.51%29.81%
Net Income747M1.21B1.38B788M747M1.13B1.4B756M730M1.03B1.24B466M546M967M1.07B803M537M820M983M374M
Net Margin %11.76%17.36%19.56%12.99%13.11%18.08%21.63%13.61%13.56%17.61%20.85%9.28%11.45%17.98%19.3%15.63%11.72%16.34%19.34%8.47%
Net Income Growth %0%7.64%-1.36%4.23%2.33%8.7%13.36%62.23%33.7%7.03%15.31%-41.97%1.68%17.93%8.95%114.71%69.94%43.36%30.37%-4.35%
EPS (Diluted)1.512.452.791.591.512.272.821.521.462.072.470.931.091.912.101.571.051.601.910.73
EPS Growth %0%7.93%-1.06%4.61%3.42%9.66%14.17%63.44%33.95%8.38%17.62%-40.76%3.81%19.38%9.95%115.07%69.35%42.86%29.05%-3.95%
EPS (Basic)1.522.462.811.601.522.292.851.531.482.092.490.941.101.932.131.591.061.611.930.74
Diluted Shares Outstanding494M495M495M496M496M496M497M498M499M499M500M501M503M506M509M511M513M513M514M513M